S. 1002 (112th): Safe Doses Act

Introduced:
May 16, 2011 (112th Congress, 2011–2013)
Status:
Died (Reported by Committee)
Sponsor
Charles “Chuck” Schumer
Senior Senator from New York
Party
Democrat
Text
Read Text »
Last Updated
May 16, 2011
Length
8 pages
Related Bills
H.R. 4223 (Related)
SAFE DOSES Act

Signed by the President
Oct 05, 2012

 
Status

This bill was introduced on March 8, 2012, in a previous session of Congress, but was not enacted.

Progress
Introduced May 16, 2011
Referred to Committee May 16, 2011
Reported by Committee Mar 08, 2012
 
Full Title

A bill to prohibit theft of medical products, and for other purposes.

Summary

No summaries available.

Cosponsors
33 cosponsors (18R, 15D) (show)
Committees

Senate Judiciary

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


8/28/2012--Reported to Senate amended.
Safe Doses Act -
Section 2 -
Amends the federal criminal code to prohibit:
(1) embezzling, stealing, obtaining by fraud or deception, or knowingly and unlawfully taking, carrying away, or concealing a medical product that has not yet been made available for retail purchase by a consumer (pre-retail medical product);
(2) knowingly and falsely making, altering, forging, or counterfeiting the labeling or documentation of such a product;
(3) knowingly possessing, transporting, or trafficking in a product involved in a prohibited act;
(4) buying or otherwise obtaining, or selling or distributing, with intent to defraud, such a product that has expired or been stolen; or
(5) attempting or conspiring to commit a prohibited act.
Makes an offense under this Act an aggravated offense if: (1) the defendant is employed by, or is an agent of, an organization in the supply chain for the product; or (2) the offense involves the use of violence, force, a threat of violence or force, or the use of a deadly weapon, results in serious bodily injury or death, or is subsequent to a prior conviction for an offense under this Act.
Prescribes criminal and civil penalties for violations of this Act, including a civil penalty of not more than the greater of 3 times the economic loss attributable to the violation or $1 million.
Section 3 -
Provides for civil forfeiture for any property which constitutes or is derived from proceeds traceable to a violation of this Act.
Section 4 -
Requires the penalties under this Act to apply for the following offenses involving a pre-retail medical product: (1) interstate and foreign travel or transportation in aid of racketeering enterprises; (2) engaging in monetary transactions in property derived from specified unlawful activity; (3) breaking into or entering carrier facilities with intent to commit larceny; and (4) the transportation, sale, or receipt of stolen property.
Section 5 -
Includes theft of medical products as a predicate offense under the Racketeer Influenced and Corrupt Organizations Act (RICO).
Section 6 -
Extends provisions authorizing wiretapping and requiring victim restitution to the crime of theft of a pre-retail medical product.
Section 8 -
Directs the U.S. Sentencing Commission to review and, if appropriate, amend the sentencing guidelines and policy statements applicable to offenses related to pre-retail medical product theft or robberies and burglaries involving controlled substances to reflect congressional intent that penalties for such offenses are sufficient to deter and punish such offenses and to appropriately account for actual harm to the public.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 1002 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus